PANews reported on November 18th that, according to Decrypt, KindlyMD (NASDAQ: NAKA), a Bitcoin vault company, saw its stock price fall nearly 10% on Monday, closing at $0.55, after failing to submit its third-quarter earnings report on time. The stock has fallen 25% over the past week and has accumulated a decline of over 95% since six months ago. The company filed a notice with the U.S. SEC last Friday, stating that it would take more time to complete its financial reporting due to the complex accounting treatment of the Nakamoto merger transaction.PANews reported on November 18th that, according to Decrypt, KindlyMD (NASDAQ: NAKA), a Bitcoin vault company, saw its stock price fall nearly 10% on Monday, closing at $0.55, after failing to submit its third-quarter earnings report on time. The stock has fallen 25% over the past week and has accumulated a decline of over 95% since six months ago. The company filed a notice with the U.S. SEC last Friday, stating that it would take more time to complete its financial reporting due to the complex accounting treatment of the Nakamoto merger transaction.

KindlyMD delayed releasing its Q3 financial report, causing its stock price to fall by nearly 10%.

2025/11/18 08:31

PANews reported on November 18th that, according to Decrypt, KindlyMD (NASDAQ: NAKA), a Bitcoin vault company, saw its stock price fall nearly 10% on Monday, closing at $0.55, after failing to submit its third-quarter earnings report on time. The stock has fallen 25% over the past week and has accumulated a decline of over 95% since six months ago.

The company filed a notice with the U.S. SEC last Friday, stating that it would take more time to complete its financial reporting due to the complex accounting treatment of the Nakamoto merger transaction.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.